Anita Pusztai

Debrecen, HB 4032, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology.

Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology.

Journal: International journal of molecular sciences

Published: February 14, 2024

Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.

Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.

Journal: Frontiers in medicine

Published: May 22, 2023

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: March 10, 2023

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.

Journal: Biomolecules

Published: September 10, 2022

Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.

Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.

Journal: Frontiers in medicine

Published: August 04, 2022

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Journal: Frontiers in medicine

Published: September 29, 2021

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Journal: Biomolecules

Published: July 26, 2021

Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Journal: RMD open

Published: July 09, 2021

Associations of vascular and bone status in arthritis patients.

Associations of vascular and bone status in arthritis patients.

Journal: Scientific reports

Published: June 13, 2021

Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients.

Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients.

Journal: BMC musculoskeletal disorders

Published: April 08, 2021

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: November 27, 2020

Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.

Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.

Journal: The Journal of rheumatology

Published: November 27, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026